• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Pathol . COVID-19 salivary signature: diagnostic and research opportunities

tetano

Editor, Senior Moderator
J Clin Pathol


. 2020 Aug 7;jclinpath-2020-206834.
doi: 10.1136/jclinpath-2020-206834. Online ahead of print.
COVID-19 salivary signature: diagnostic and research opportunities


Dipak Sapkota[SUP] 1 [/SUP], Tine Merete S?land[SUP] 2 3 [/SUP], Hilde Kanli Galtung[SUP] 2 [/SUP], Lars Peter Sand[SUP] 2 [/SUP], Simone Giannecchini[SUP] 4 [/SUP], Kelvin K W To[SUP] 5 6 7 [/SUP], Maria Cassia Mendes-Correa[SUP] 8 [/SUP], Daniel Giglio[SUP] 9 [/SUP], Bengt Hass?us[SUP] 10 11 [/SUP], Paulo Henrique Braz-Silva[SUP] 12 13 [/SUP]



Affiliations

Abstract

The COVID-19 (caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)) epidemic started in Wuhan (Hubei Province, China) in mid-December 2019 and quickly spread across the world as a pandemic. As a key to tracing the disease and to implement strategies aimed at breaking the chain of disease transmission, extensive testing for SARS-CoV-2 was suggested. Although nasopharyngeal/oropharyngeal swabs are the most commonly used biological samples for SARS-CoV-2 diagnosis, they have a number of limitations related to sample collection and healthcare personnel safety. In this context, saliva is emerging as a promising alternative to nasopharyngeal/oropharyngeal swabs for COVID-19 diagnosis and monitoring. Saliva collection, being a non-invasive approach with possibility for self-collection, circumvents to a great extent the limitations associated with the use of nasopharyngeal/oropharyngeal swabs. In addition, various salivary biomarkers including the salivary metabolomics offer a high promise to be useful for better understanding of COVID-19 and possibly in the identification of patients with various degrees of severity, including asymptomatic carriers. This review summarises the clinical and scientific basis for the potential use of saliva for COVID-19 diagnosis and disease monitoring. Additionally, we discuss saliva-based biomarkers and their potential clinical and research applications related to COVID-19.

Keywords: diagnostic techniques and procedures; infections; molecular biology; salivary glands; virology.
 
Back
Top Bottom